Peetz Christopher's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Mar 17, 2026
- Accession no.
- 0001614740-26-000009
- Filed
- Mar 17, 2026
- Trade date
- Mar 15-16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peetz ChristopherCIK 0001614740 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Common Stock | MOption exerciseAcquired | +25,000 | –F1 | – | 185,294 | Direct | |
| Mar 15, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | –F1 | – | 235,294 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −40,985 | $91.98 | −$3,769,800.3 | 194,309 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 0 | Direct | |
| Mar 15, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 25,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 2 transactions in Table I.